NOV 03, 2018 01:54 PM PDT

Potential new Tuberculosis Treatment Found in Dirt

WRITTEN BY: Carmen Leitch

A bacterium called Mycobacterium tuberculosis causes the disease tuberculosis (TB), which is treated with antibiotics. The pathogen is able to mutate, however, and evade therapeutics like rifamycin. Resistance to rifamycin or Rif has been steadily increasing, making it much harder to help TB patients get well. New research reported in Nature Communications may have found a solution to the resistance problem, however. Scientists discovered an antibiotic in dirt, which can destroy the pathogenic microbe.

Soil is a rich source of bacteria, some of which produce molecules that act as natural antibiotics. / Credit: Jacob Arthur Pritchard for The Rockefeller University

The drug that has been used to treat TB, Rif, targets a bacterial enzyme called RNA polymerase (RNAP). If the RNAP mutates, however, the drug often stops working. Researchers decided to search for a new antibiotic that acted similarly to Rif, but kept working even after mutations occurred in the RNAP. 

"Rifamycin is naturally produced by a bacterium," said Sean F. Brady, the Evnin Professor. "So I wanted to find out whether nature had also made Rif analogs - molecules that look like rifamycin, but that have slight differences."

In soil, bacteria have to compete with one another. They might create toxins to gain an edge in that competition. Rif is one such bacterial toxin. The researchers combed through the soil using genomic tools that could identify microbes with genes that would indicate the presence of a molecule with similarities to Rif. They were able to find natural antibiotics called kanglemycins, or kangs; they have genes in common with rifamycin. They also looked to be capable of targeting bacteria that Rif cannot.

Because the tuberculosis bacterium was able to evolve so it could evade Rif, it’s possible a similar thing happened in soil. That may have led to the creation of kangs, in turn.

"It's possible that natural antibiotics are under the same selective pressure that we're putting antibiotics under in the clinic," explained Brady. "And if that's the case, then we would see natural analogs to rifamycin, like kangs, that overcome resistance."

Scientists Elizabeth Campbell, a research associate professor, Seth A. Darst, the Jack Fishman Professor, and senior research associate Mirjana Lilic wanted to know whether the newly found antibiotics had any efficacy against tuberculosis. They began by analyzing their structure, and found that while kangs resemble rifamycin, there are unique features to these antibiotics.  The addition of a sugar and an acid to the core structure of the molecule give it a new way to attach to RNAP. That enables the kangs to disrupt bacteria that aren’t affected by Rif.

"We found that the extra sugar allows the kanglemycin to dock into a pocket of RNAP that other drugs didn't take advantage of," explained Campbell. Before this study, she said, scientists did not know that such a pocket even existed. Its discovery has opened up a new target in drug design.

"We'd still like to see increased potency and broader activity against resistant bugs," added Campbell. "But this study tells us that we're on the right track."


Sources: AAAS/Eurekalert! Via Rockefeller University, Nature Communications

About the Author
  • Experienced research scientist and technical expert with authorships on 28 peer-reviewed publications, traveler to over 60 countries, published photographer and internationally-exhibited painter, volunteer trained in disaster-response, CPR and DV counseling.
You May Also Like
NOV 06, 2018
Videos
NOV 06, 2018
Towards a Universal Flu Vaccine
Researchers have to design a new flu vaccine every year. But there are efforts to create a vaccine that works against all strains....
NOV 07, 2018
Videos
NOV 07, 2018
The Threat of Neglected Tropical Diseases
Did you know that around one billion people suffer from a neglected tropical disease?...
DEC 06, 2018
Microbiology
DEC 06, 2018
A Bacterial Protein can Encourage Cancer Development
It's been suggested that a fifth of all cancers are caused by microbial infections, and new work indicates that the estimate is probably low....
DEC 08, 2018
Genetics & Genomics
DEC 08, 2018
The Plague May Have led to the Decline of Neolithic Settlements
An international team of European researchers has discovered a new strain of the bacteria that causes plague....
JAN 07, 2019
Videos
JAN 07, 2019
Scientists Learn More About a Foodborne Pathogen
We're surrounded by bacteria; they live everywhere in our environment and even inside of our bodies. While many are harmless, some are pathogenic....
JAN 17, 2019
Microbiology
JAN 17, 2019
Ulcerative Colitis Relieved by Fecal Microbiota Transplant
The community of microbes in our gut is critical to our health. If it's out of balance, researchers are investigating whether 'healthy' fecal material can restore it....
Loading Comments...